# A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D

> **NCT05378672** · PHASE3 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 8 (actual)

## Conditions studied

- Hypoglycemia
- Type 1 Diabetes

## Interventions

- **DRUG:** Dasiglucagon

## Key facts

- **NCT ID:** NCT05378672
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-09
- **Primary completion:** 2024-10-29
- **Final completion:** 2024-12-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378672, "A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05378672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*